Table 3.
Demographics of internal Irish validation cohort
| All (n = 80) | Pauci-Inflammatory (n = 15) | Inflammatory (Viral/Non-viral) (n = 65) | |
|---|---|---|---|
| Exacerbations (n) | 188 | 28 | 160 |
| Male, n (%) | 41 (51%) | 8 (50%) | 33 (52%) |
| Age (yr) | 31.0 (9.1) | 29.5 (9.4) | 31.7 (9.4) |
| FEV1 (% predicted) | 45.5 (19.6) | 63.3 (19.1) | 41.2 (17.3) |
| FEV1 (L) | 1.89 (0.93) | 2.64 (0.87) | 1.71 (0.85) |
| BMI (kg/m2) | 20.9 (3.21) | 21.2 (2.3) | 20.8 (3.5) |
| CFRD, n (%) | 30 (37.5) | 5 (31%) | 25 (39%) |
| Chronic PA | 48 (60%) | 11 (69%) | 37 (58%) |
Definition of abbreviations: BMI = body mass index; CFRD = cystic fibrosis-related diabetes; FEV1 = forced expiratory volume in 1 second; PA = Pseudomonas aeruginosa.
Mean (standard deviation) unless otherwise stated.